All News #Library
Rare Diseases
Lantern Pharma Debuts Zeta.Ai For Rare Cancer Drug Discovery
14 Apr 2026 //
PHARMIWEB
FDA Grants Orphan Drug Status to LP-284 for Soft Tissue Sarcoma
20 Jan 2026 //
BUSINESSWIRE
Lantern Pharma Gets FDA Rare Pediatric Designations For LP-184
23 Sep 2024 //
BUSINESSWIRE
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284
30 Nov 2023 //
BUSINESSWIRE
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284
05 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support